Biosimilar medicines used for cancer therapy in Europe: a review.

Santos, Sofia B; Sousa Lobo, José M; Silva, Ana C

Santos, Sofia B; Sousa Lobo, José M; Silva, Ana C.

Afiliação

Santos SB; UFP Energy, Environment and Health Research Unit (FP-ENAS), Fernando Pessoa University, Porto, Portugal.
Sousa Lobo JM; UCIBIO, ReQuimTe, Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto University, Porto, Portugal.
Silva AC; UFP Energy, Environment and Health Research Unit (FP-ENAS), Fernando Pessoa University, Porto, Portugal; UCIBIO, ReQuimTe, Laboratory of Pharmaceutical Technology/Centre of Research in Pharmaceutical Sciences, Faculty of Pharmacy, Porto University, Porto, Portugal. Electronic address: acsilva@ufp.edu.pt.

Drug Discov Today ; 24(1): 293-299, 2019 01.

Article em En | MEDLINE | ID: mdl-30244082

Assuntos

Antineoplásicos/uso terapêutico; Medicamentos Biossimilares/uso terapêutico; Neoplasias/tratamento farmacológico; Animais; Europa (Continente); Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Neoplasias / Antineoplásicos Limite: Animals / Humans País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google